US Physical Therapy Inc (USPH)
105.20
+1.56
(+1.51%)
USD |
NYSE |
May 03, 16:00
US Physical Therapy Cash from Financing (Quarterly): -13.28M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -13.28M |
| September 30, 2023 | -12.48M |
| June 30, 2023 | 107.68M |
| March 31, 2023 | 2.343M |
| December 31, 2022 | 19.77M |
| September 30, 2022 | -10.05M |
| June 30, 2022 | 16.08M |
| March 31, 2022 | -0.043M |
| December 31, 2021 | 73.35M |
| September 30, 2021 | -15.29M |
| June 30, 2021 | 4.772M |
| March 31, 2021 | -19.45M |
| December 31, 2020 | 5.684M |
| September 30, 2020 | -34.84M |
| June 30, 2020 | -75.82M |
| March 31, 2020 | 65.55M |
| December 31, 2019 | -14.26M |
| September 30, 2019 | -18.12M |
| June 30, 2019 | 20.17M |
| March 31, 2019 | -12.06M |
| December 31, 2018 | -25.84M |
| September 30, 2018 | -9.043M |
| June 30, 2018 | 2.466M |
| March 31, 2018 | -15.24M |
| December 31, 2017 | -6.854M |
| Date | Value |
|---|---|
| September 30, 2017 | -19.06M |
| June 30, 2017 | 6.721M |
| March 31, 2017 | 8.131M |
| December 31, 2016 | 6.261M |
| September 30, 2016 | -10.79M |
| June 30, 2016 | -13.64M |
| March 31, 2016 | 3.877M |
| December 31, 2015 | -9.171M |
| September 30, 2015 | 1.585M |
| June 30, 2015 | -7.784M |
| March 31, 2015 | 5.482M |
| December 31, 2014 | -17.61M |
| September 30, 2014 | -1.564M |
| June 30, 2014 | -7.193M |
| March 31, 2014 | 3.964M |
| December 31, 2013 | 22.48M |
| September 30, 2013 | -4.942M |
| June 30, 2013 | -8.846M |
| March 31, 2013 | 0.187M |
| December 31, 2012 | -6.174M |
| September 30, 2012 | -6.965M |
| June 30, 2012 | -8.149M |
| March 31, 2012 | -2.169M |
| December 31, 2011 | -9.455M |
| September 30, 2011 | 4.873M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-75.82M
Minimum
Jun 2020
107.68M
Maximum
Jun 2023
5.356M
Average
-0.043M
Median
Mar 2022
Cash from Financing (Quarterly) Benchmarks
| Encompass Health Corp | -40.60M |
| Pediatrix Medical Group Inc | -4.747M |
| US Neurosurgical Holding Inc | 0.00 |
| The Oncology Institute Inc | -1.781M |
| American Oncology Network Inc | -- |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 26.84M |
| Cash from Investing (Quarterly) | -8.414M |
| Free Cash Flow | 72.68M |
| Free Cash Flow Per Share (Quarterly) | 1.641 |
| Free Cash Flow to Equity (Quarterly) | 26.98M |
| Free Cash Flow to Firm (Quarterly) | 19.41M |
| Free Cash Flow Yield | 4.87% |